Tech Company Financing Transactions
DBV Technologies Funding Round
DBV Technologies, based in Montrouge, secured $15 million in investment from Sofinnova Ventures and Apax Partners.
Transaction Overview
Company Name
Announced On
1/23/2006
Transaction Type
Venture Equity
Amount
$15,044,200
Round
Undisclosed
Investors
Sofinnova Ventures (Lead Investor) (Rafale Tordjman)
Apax Partners (Laurent Ganem)
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
177-181 avenue Pierre Brossolette
Montrouge, 92120
France
Montrouge, 92120
France
Phone
Website
Email Address
Overview
Clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Tassé
Chief Financial Officer
Sébastien Robitaille
Chief Medical Officer
Pharis Mohideen
Chief Scientific Officer
Hugh Sampson
VP - Human Resources
Caroline Daniere
Browse more venture capital transactions:
Prev: 1/23/2006: ITA Software venture capital transaction
Next: 1/23/2006: Click & Buy venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs